We should be scoring tries.
To demonstrate construct validity, the score of an instrument should be correlated with scores of other validated instruments that measure similar concepts.
The quality assessment scores should be viewed with caution; such scores are subjective and may not take into consideration factors beyond the quality assessment scale used.
Ideally, these endpoints should be combined with scores obtained from validated pain assessment instruments.
To this end, the matching measures should be complemented with scores that assess the biological relevance of predicted complexes based on the colocalization and coannotation of the constituent proteins instead of relying on a predefined gold standard.
In a country with limited resources, scoring should be prioritized with meaningful and clinical relevance.
Following the Illumina guidelines, all SNPs with a score below 0.4 should be discarded; SNPs with a score above 0.4 accepted, with SNPs scoring above 0.6 being used preferentially.
Furthermore, the correlation between physical component items and the PCS score should be higher than with the MCS score and vice versa, i.e. the correlation between mental component items and the MCS score should be higher than with the PCS score [ 7].
A total quality score has been noted for ease of comparison across studies; however, these scores should be interpreted with caution as it should not be assumed that each of the quality criteria should be given equal weighting.
Further evaluation of the responsiveness of enthesitis evaluation should be performed on scoring systems with evidence of statistical difference.
